-
-
Nitrogen and phosphorus constrain the CO2 fertilization of global plant biomass
-
-
The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression
-
-
The First, Multicenter, Double-Blind, Randomized, Parallel-Group Study of Certolizumab Pegol in Early Rheumatoid Arthritis Demonstrates Inhibition of Joint Damage Progression
-
-
Efficacy and safety of certolizumab pegol plus methotrexate in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: the J-RAPID randomized, placebo-controlled trial
-
-
Efficacy and safety of certolizumab pegol without methotrexate co-administration in Japanese patients with active rheumatoid arthritis: The HIKARI randomized, placebo-controlled trial
-
-
THE FIRST EARLY RHEUMATOID ARTHRITIS, CERTOLIZUMAB PEGOL, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP STUDY: C-OPERA, IN PATIENTS FULFILLING THE 2010 ACR/EULAR CLASSIFICATION CRITERIA, DEMONSTRATES INHIBITION OF JOINT DAMAGE PROGRESSION